CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 9 enrolled
Drug / intervention
lubiprostonedrug
Likely dose
lubiprostone 24 microgramfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00706004
NCT00706004N/ACompleted
CompareCT.gov

Short Term Safety and Efficacy of Lubiprostone in Adults With Cystic Fibrosis

University of Arkansas·interventional·Posted Jun 27, 2008·Updated Apr 18, 2011

In Brief

A clinical study evaluating lubiprostone for Constipation and Cystic Fibrosis. Completed, enrolled 9 participants across 1 site.

Detailed Summary

The purpose of this study is to determine the short term safety and effectiveness of lubiprostone when used for constipation in adults with cystic fibrosis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsConstipation, Cystic Fibrosis
CountriesUnited States
CollaboratorsTakeda Pharmaceuticals North America, Inc.

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 27, 2008
Enrollment StartJul 1, 2008
Primary CompletionDec 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 18.0 years ago

Interventions

lubiprostonedrug

lubiprostone 24 microgram capsule taken twice daily for 4 weeks